| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8725399 | Clinics and Research in Hepatology and Gastroenterology | 2018 | 11 Pages |
Abstract
Knowledge in this field is still at an early stage. Evidence derived from small trials of medium quality on ESLD patients suggests that APA is safe, without increasing portal hypertension. Further research is very likely to have an important impact on our confidence in the intervention effect.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Raffaele Brustia, Eric Savier, Olivier Scatton,